Belite Bio’s (BLTE) “Overweight” Rating Reaffirmed at Cantor Fitzgerald
Belite Bio (NASDAQ:BLTE – Get Free Report)‘s stock had its “overweight” rating reaffirmed by investment analysts at Cantor Fitzgerald in a note issued to investors on Thursday,Benzinga reports. Other research analysts also recently issued reports about the stock. Benchmark restated a “buy” rating and set a $80.00 price objective on shares of Belite Bio in […]
Belite Bio (NASDAQ:BLTE – Get Free Report)‘s stock had its “overweight” rating reaffirmed by investment analysts at Cantor Fitzgerald in a note issued to investors on Thursday,Benzinga reports. Other research analysts also recently issued reports about the stock. Benchmark restated a “buy” rating and set a $80.00 price objective on shares of Belite Bio in […]
